Suchergebnisse - "Iacoboni, Gloria"

PubPharm (67)

1

Efficacy of CAR T-Cell Therapy is Not Impaired by Previous Bispecific Antibody Treatment in Large B-Cell Lymphoma

enthalten in: Blood | 2024

von Crochet, G. | Iacoboni, G. | Couturier, A. | +23

2

Applying the EHA/EBMT grading for ICAHT after CAR-T : comparative incidence and association with infections and mortality

enthalten in: Blood advances | 2024

von Rejeski, K. | Wang, Y. | Hansen, D. | +14

3

Transient acute kidney injury after chimeric antigen receptor T-cell therapy in patients with hematological malignancies

enthalten in: Clinical kidney journal | 2024

von León-Román, J. | Iacoboni, G. | Bermejo, S. | +8

4

Is estimated exposure an accurate surrogate for measured fludarabine levels in CAR T-cell patients?

enthalten in: Blood advances | 2024

von Sánchez-Salinas, M. | Miarons, M. | Troconiz, I. | +4

5

Recent Bendamustine Treatment Before Apheresis Has a Negative Impact on Outcomes in Patients With Large B-Cell Lymphoma Receiving Chimeric Antigen Receptor T-Cell Therapy

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Iacoboni, G. | Navarro, V. | Martín-López, A. | +21

6

Torque Teno Virus plasma DNA load : a novel prognostic biomarker in CAR-T therapy

enthalten in: Bone marrow transplantation | 2024

von Benzaquén, A. | Giménez, E. | Iacoboni, G. | +24

7

Impact of SCHOLAR-1 Criteria on Chimeric Antigen Receptor T Cell Therapy Efficacy in Aggressive B Lymphoma : A Real-World GELTAMO/GETH Study

enthalten in: Transplantation and cellular therapy | 2023

von Bastos-Oreiro, M. | Gutierrez, A. | Iacoboni, G. | +22

8

CAR T-cell therapy versus allogeneic HSCT for relapsed or refractory mantle cell lymphoma

enthalten in: The Lancet. Haematology | 2023

von Iacoboni, G. | Dietrich, S. | Liebers, N.

9

The CAR-HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL

enthalten in: American journal of hematology | 2023

von Rejeski, K. | Wang, Y. | Albanyan, O. | +17

10

Early quantification of anti-CD19 CAR T cells by flow cytometry predicts response in R/R DLBCL

enthalten in: Blood advances | 2023

von Blumenberg, V. | Busch, G. | Baumann, S. | +24

1
2
3
4
5
6
7
Nächster »
[7]